TotalMarketCap

Jazz Pharmaceuticals

JAZZNasdaq IrelandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$14.583 B

$227.19 -3.18%

Close of 6 Nov 2026

As of 6 Nov 2026, Jazz Pharmaceuticals (JAZZ) has a market capitalization of $14.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.27B

#744 by revenue

Earnings

-$356.1M

Loss-making

Shares outstanding

64,189,052

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #25Alnylam PharmaceuticalsALNY$21.0B
  2. #26Ascendis Pharma A/SASND$16.7B
  3. #27Jazz PharmaceuticalsJAZZ$14.6B
  4. #28BridgeBio PharmaBBIO$14.5B
  5. #29Dr Reddys LaboratoriesRDY$12.1B

What if Jazz Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$439,901.71

Per share 1,936× higher

Bitcoin $1.53T

$23,802.32

Per share 105× higher

Apple $5.02T

$78,140.78

Per share 344× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Jazz Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.